Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,921,230 papers from all fields of science
Search
Sign In
Create Free Account
Retroperitoneal Lymph Node Dissection
Known as:
RPLND
The surgical removal of retroperitoneal lymph nodes from the abdominal cavity. The surgery is a therapeutic treatment for testicular cancer…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Lymph node excision
lymph nodes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Plasma miR371 for the detection of viable germ cell tumor in testicular cancer patients with enlarging or post chemotherapy residual nodes.
L. Nappi
,
M. Thi
,
+7 authors
C. Kollmannsberger
2018
Corpus ID: 79947079
569Background: The pathological constitution of post-chemotherapy residual disease (PCRD) or enlarged nodes in clinical stage I…
Expand
2016
2016
[Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
P. Paffenholz
,
D. Pfister
,
Axel Heidenreich
Der Urologe (Ausg. A)
2016
Corpus ID: 115957661
INTRODUCTION Postchemotherapy residual tumour resection (PC-RTR) is an integral part of the multimodal therapy for advanced…
Expand
2015
2015
Desmoid Tumor Mimicking Port Site Recurrence after Laparoscopic Retroperitoneal Lymph Node Dissection for Metastatic Testicular Tumor: A Case Report
Y. Hayashi
,
Y. Ishizuya
,
+6 authors
K. Nishimura
2015
Corpus ID: 36518180
Background: Desmoid tumor is a rare benign soft tissue tumor which commonly affects the trunk and extremities. Case presentation…
Expand
2012
2012
TESTICULAR GERM CELL TUMOURS : ACTIVE SURVEILLANCE VERSUS PRIMARY CHEMOTHERAPY VERSUS NERVE SPARING RETROPERITONEAL LYMPHADENECTOMY
A. Heidenreich
,
David Pfister
2012
Corpus ID: 10649330
CS I is defined negative or declining tumour markers to their half-life following orchidectomy and negative imaging studies of…
Expand
2009
2009
The Effects of Chemotherapy on Metastatic Testicular Germ Cell Tumors
I. Damjanov
,
O. Hes
2009
Corpus ID: 11567497
Modern chemotherapy combined with surgery can achieve complete cure in over 90% of all patients with malignant testicular germ…
Expand
Review
2006
Review
2006
Clinical outcome of patients managed for late relapse of germ cell tumor.
D. Sharp
,
B. Carver
,
+4 authors
J. Sheinfeld
Journal of Clinical Oncology
2006
Corpus ID: 33477461
4550 Background: The significance of late relapse (LR) of germ cell tumor (GCT) and its association with poor survival is…
Expand
2006
2006
Predicting recurrence following post-chemotherapy retroperitoneal lymph node dissection for residual fibrosis or teratoma.
B. Carver
,
B. Shayegan
,
+4 authors
J. Sheinfeld
Journal of Clinical Oncology
2006
Corpus ID: 25387739
4551 Background: The current recommendation for the management of patients with the histologic finding of fibrosis or teratoma at…
Expand
2005
2005
Post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumors: The impact of time
B. Carver
,
R. Motzer
,
D. Bajorin
,
J. Stasi
,
G. Bosl
,
J. Sheinfeld
2005
Corpus ID: 79259978
4581 Background: The integration of chemotherapy and surgery for metastatic non-seminomatous germ cell tumors (NSGCT) results in…
Expand
2001
2001
Reoperative RPLND for germ cell tumor; initial presentation, complications and outcome
J. McKiernan
,
J. Sheinfeld
,
J. Bacik
,
Robert J. Motzer
,
D. Bajorin
,
G. Bosl
2001
Corpus ID: 57252376
1990
1990
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
N. Aass
,
S. Fosså
,
+4 authors
O. Kaalhus
British Journal of Urology
1990
Corpus ID: 39059096
We present 8 years' experience of primary retroperitoneal lymph node dissection (RLND) in 190 patients with low stage non…
Expand